Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Advancements in Obesity Medicine in 2023: Breakthroughs and Shifting Perspectives on Treatment
"How does 2023 compare to previous years in terms of advancements in obesity medicine?
Patient Care Online asked this question in a recent interview with Angela Fitch, MD, president of the Obesity Medicine Association, in a recent interview. In the video below, Dr Fitch discusses the approval of tirzepatide for use in adults requiring chronic weight management as well as how clinician perspectives on obesity as a disease state and treatment options are changing.
Dr Fitch is also the founder and chief medical officer at knownwell and the former co-director of the Massachusetts General Hospital Weight Center and faculty at Harvard Medical School.
Related Videos
Related Content
Obesity Linked to Faster Alzheimer Disease Progression in Longitudinal Blood Biomarker Analysis
December 2nd 2025Article
Biomarker trajectories over 5 years in study participants with AD show steeper rises in pTau217, NfL, and amyloid burden among those with obesity, highlighting risk factor relevance.
